Tribeca’s Post

Healthy Roster acquires Sway Medical, expanding digital reach in sports medicine. Columbus-based Healthy Roster has acquired concussion tech leader Sway Medical, uniting two sports medicine innovators into one digital platform for injury documentation and athlete wellness—backed by New York’s Level Equity. ✅ The story: https://lnkd.in/ePFyWkHd -- OhioX | Ohio Tech Events

To celebrate the launch of Vital Stories—a new creative storytelling program from Tribeca Studios and Eli Lilly and Company—Jonathan Levy (Agent, TV Lit) participated in the program’s first-ever creative summit, held in New York City. The summit focused on supporting filmmakers directly on their projects and deepening their skillsets. Attendees received guidance from both film and medical experts, explored best practices from Lilly’s Advancing Health Storylines in Popular Entertainment toolkit, and engaged with leading industry voices across sessions. Vital Stories aims to empower filmmakers to tell authentic, inclusive, and emotionally resonant stories about health experiences. It was brought to life through UTA Entertainment Marketing’s partnership with Lilly. The initiative ladders into UTA’s broader work with Lilly on its commitment to addressing the underrepresentation and misrepresentation of health conditions in media by supporting creators who integrate patient and treatment narratives into everyday storytelling. https://lnkd.in/g7rc9EZa

Gathering with leaders from across the Philadelphia life sciences ecosystem yesterday was energizing as we look ahead to J.P. Morgan and a shifting deal-making environment. It was especially valuable to hear perspectives from Stephen Squinto and Anya Schiess, whose clarity around focus, capital efficiency, and disciplined platform execution really resonated. What stands out right now: • Patent cliffs are accelerating the need for thoughtful innovation. • Leadership and operational rigor differentiate. • Clinical value requires both efficacy and safety — clearly and defensibly. • Platforms succeed when they focus early and expand with intention. This is the work underway at SOLUtion Medical — building a cohesive, end-to-end drug-device platform to simplify complex injectable therapies and strengthen access where it matters most. The opportunity ahead is real — and we’re ready to be part of what comes next.

The Spanios team, together with the rapidly expanding community dedicated to Innovative New Approach Methodologies (NAMs), celebrates this significant milestone achieved by the UK Government. This moment marks a pivotal step forward in advancing the adoption and implementation of NAMs within biomedical research and healthcare. NAMs are designed to meet critical health needs by providing more reliable drug development pathways. In addition, they advocate for the replacement of animal testing, aiming to create greater impacts not only on human health but also on environmental sustainability. Despite these clear benefits, the widespread integration of NAMs faces challenges. In particular, regulatory barriers and hurdles in preclinical research often slow or hinder the adoption of these innovative methodologies. This comprehensive actions by the UK Government directly support the transition to NAMs. Legislative initiatives are streamlining the approval process for new treatments, making it easier for promising therapies based on NAMs to reach patients. Simultaneously, regulatory changes are being implemented to adapt existing frameworks to better accommodate NAMs, especially by improving validation processes. These measures collectively create a more favorable environment for NAMs to thrive within biomedical research and healthcare. The movement toward NAMs began nearly a century ago and has grown in its impact, potential, and promise. Rather than resisting the inevitable progression of scientific innovation, it is time to look forward with optimism and actively shape the future of research and healthcare. By embracing these changes, we can realize the full benefits of NAMs for both human health and the environment. #Spanios #NAMbased #FDAModernisationAct #FDAModernisationAct2point0, #FDAModernizationAct3point0, #itsagobalmove #Lead #Tumoroids #ComplementARIE #FNIHVQN Bhuvanesh Dave, Preethi Samuel, PhD https://lnkd.in/dQs6CsRb

Great move by UK govt to push for NAM models- More of this is needed to accelerate therapeutic approval and better options for patients.

What does true inclusion in clinical research look like? At KP-Morgan Group ’s 9th Annual OECT Summit in Toronto, Naty Diaz, CEO of Prestige Clinical Research Center, Inc, shared how community-based sites and lasting relationships are key to building trust and inclusion in trials. #XtalksOpenMic #ClinicalDiversity #ClinicalResearch

Project: Patient Meet Science 🧬 We recently worked on this project for a client — a concept that connects human care with medical innovation. Here’s how the process went: • We started by writing a detailed script and shared it with the client for feedback. • After a few small revisions, we moved to the storyboard phase to visualize the entire flow. • Once the storyboard was approved, our team began production — a full week of non-stop work to bring every frame to life. • The background music was chosen by the client exactly as it is in the final video. The result is this cinematic short, Patient Meet Science — where technology and empathy come together in a hospital setting.

𝗖𝗹𝗶𝗻𝗶𝗰𝗮𝗹 𝗥𝗲𝘀𝗲𝗮𝗿𝗰𝗵 𝗠𝘆𝘁𝗵𝘀 𝗧𝗵𝗮𝘁 𝗗𝗲𝘀𝗲𝗿𝘃𝗲 𝘁𝗼 𝗥𝗲𝘀𝘁 𝗶𝗻 𝗣𝗲𝗮𝗰𝗲  There’s nothing spooky about clinical research but some myths just won’t die. Let’s set the record straight:  𝗠𝘆𝘁𝗵: People in clinical trials are experimented on.  𝗙𝗮𝗰𝘁: Participants are informed partners who choose to take part after reviewing all details of the study. The informed consent process ensures full transparency about what’s involved.  𝗠𝘆𝘁𝗵: Clinical trials aren’t safe.  𝗙𝗮𝗰𝘁: Safety comes first. Every trial must be approved by independent ethics and safety committees, and researchers continually monitor results to protect participants.  𝗠𝘆𝘁𝗵: Trial participants get less medical care.  𝗙𝗮𝗰𝘁: Participants often receive attentive, high-quality care and access to the latest advances in medicine, while helping shape the future of healthcare. So this Halloween, don’t let myths creep you out. 𝗛𝗮𝗽𝗽𝘆 𝗛𝗮𝗹𝗹𝗼𝘄𝗲𝗲𝗻! 𝗖𝗹𝗶𝗻𝗶𝗰𝗮𝗹 𝗿𝗲𝘀𝗲𝗮𝗿𝗰𝗵 𝗶𝘀𝗻’𝘁 𝗮 𝗺𝘆𝘀𝘁𝗲𝗿𝘆, 𝗶𝘁’𝘀 𝗮 𝗽𝗮𝘁𝗵 𝘁𝗼 𝗽𝗿𝗼𝗴𝗿𝗲𝘀𝘀.  #ClinicalResearch #ScienceNotScary #Halloween2025

Speak openly: our final company value that focuses on sharing opinions honestly, including listening as well as speaking. We work to create a culture, both inside and out, that is willing to share, listen and be honest, driving empathy, empowerment and understanding. Internally, we thrive on creativity and listening to patients to make our experiences as genuine as they can be. Externally, we aim to encourage conversations, to drive better understanding from patients; and allow everyone to share their ideas – which has led to some fantastic outcomes. https://ow.ly/z2R350XomR2 #PatientVoice #ALifeinaDay